The acquisition tightens BBK's ties to the team that helped to develop its patient and site engagement mobile app, My Clinical Study Buddy.
There have been roughly two dozen digital health-related FDA clearances so far in 2014.
Apple's HealthKit data-sharing platform for mobile health apps has been pulled from the iPhone 6's operating system after an upgrade to iOS 8 disrupted cellular service, resulting in a bucketful of delayed app launches or upgrades, to the benefit of competitors.
The market for mHealth data aggregation platforms has become increasingly congested over the past year, with Apple and Google joining the more healthcare industry-focused Validic. Now Vivametrica has joined the space, outlining plans for a platform that fixes the inconsistencies in data from consumer mHealth products and combines them with outputs from medical devices.
Less than one year has passed since a $760,000, Mark Cuban-backed seed round put Validic on the map, but the firm and its health data aggregation platform have come a long way in the intervening months. And with Validic's scale and ambition growing, the company has raised $5 million in first round funding.
Over the past year, many tech heavyweights have begun moving into the mHealth sector. Developers got an early look at Google's offering this week, with the search giant releasing a preview version of its APIs for health app developers.
Falling sales of personal computers have chipped away at one of the cornerstones of Intel's business over the past few years. The chipmaker has responded by diversifying and this week made three such moves, each of which has implications for the life sciences sector.
With the likes of Pfizer keen for clinical trial participants to track their personal health data--and Apple and Google readying to provide the technology--mobile and wearables look set to make an impact on research. But does the public want to give researchers access to their data?
Rising use of Fitbit wristbands, Withings scales and other self-tracking devices mean individuals have access to a pool of personal health data that in some respects far exceeds what clinical trials gather. Now, Validic has secured funding from Dallas Mavericks-owner Mark Cuban to bring the devices into healthcare.
Qlucore, a provider of scientific software, has won €600,000 ($801,360) over three years from the European Commission's 7th Framework Program to develop algorithms for use in personalizing treatment of hepatitis C virus.